These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20506379)

  • 1. The biology and pathology of vitamin D control in bone.
    Bell TD; Demay MB; Burnett-Bowie SA
    J Cell Biochem; 2010 Sep; 111(1):7-13. PubMed ID: 20506379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
    Haussler MR; Haussler CA; Bartik L; Whitfield GK; Hsieh JC; Slater S; Jurutka PW
    Nutr Rev; 2008 Oct; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of vitamin D in bone.
    Goltzman D
    Histochem Cell Biol; 2018 Apr; 149(4):305-312. PubMed ID: 29435763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of vitamin D receptor action.
    Demay MB
    Ann N Y Acad Sci; 2006 Apr; 1068():204-13. PubMed ID: 16831920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.
    Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y
    Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D resistance.
    Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D.
    Brown AJ; Dusso A; Slatopolsky E
    Am J Physiol; 1999 Aug; 277(2):F157-75. PubMed ID: 10444570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Biological Activities of Vitamin D and Its Receptor in Relation to Calcium and Bone Homeostasis, Cancer, Immune and Cardiovascular Systems, Skin Biology, and Oral Health.
    Khammissa RAG; Fourie J; Motswaledi MH; Ballyram R; Lemmer J; Feller L
    Biomed Res Int; 2018; 2018():9276380. PubMed ID: 29951549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention.
    Bartik L; Whitfield GK; Kaczmarska M; Lowmiller CL; Moffet EW; Furmick JK; Hernandez Z; Haussler CA; Haussler MR; Jurutka PW
    J Nutr Biochem; 2010 Dec; 21(12):1153-61. PubMed ID: 20153625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer.
    Chuma M; Endo-Umeda K; Shimba S; Yamada S; Makishima M
    Biol Pharm Bull; 2012; 35(4):582-7. PubMed ID: 22466564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor as a drug discovery target.
    Pinette KV; Yee YK; Amegadzie BY; Nagpal S
    Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired vitamin D sensitivity.
    Máčová L; Bičíková M; Hampl R
    Physiol Res; 2018 Nov; 67(Suppl 3):S391-S400. PubMed ID: 30484666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor.
    Malloy PJ; Wang J; Srivastava T; Feldman D
    Mol Genet Metab; 2010 Jan; 99(1):72-9. PubMed ID: 19815438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene.
    Guo B; Aslam F; van Wijnen AJ; Roberts SG; Frenkel B; Green MR; DeLuca H; Lian JB; Stein GS; Stein JL
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):121-6. PubMed ID: 8990171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors.
    Endo I; Inoue D; Mitsui T; Umaki Y; Akaike M; Yoshizawa T; Kato S; Matsumoto T
    Endocrinology; 2003 Dec; 144(12):5138-44. PubMed ID: 12959989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.